Why CME Group Inc. (NASDAQ: CME) At $164.88 Is Worth Your Money?

CME Group Inc. (NASDAQ:CME) does about 1.94M shares in volume on a normal day but saw 2098557 shares change hands in Wednesday trading.

CME Group Inc. (NASDAQ:CME) does about 1.94M shares in volume on a normal day but saw 2098557 shares change hands in Wednesday trading. The company now has a market cap of 59.59B USD. Its current market price is $164.88, marking a decrease of -0.67% compared to the previous close of $166.00. The 52 week high reached by this stock is $225.36 whilst the lowest price level in 52 weeks is $131.80. The script in recent trading has seen the stock touch a high of $168.36 and a low of $164.7801.

CME Group Inc. (CME) has a 20-day trading average at $166.98 and the current price is -26.84% off the 52-week high compared with 25.10% distance from its 52-week low. The 50-day simple moving average of the closing price is $173.53 and its 200-day simple moving average is $190.94. If we look at the stock’s price movements over the week, volatility stands at 1.78%, which increases to 2.10% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 40.67 to suggest the stock is neutral.

21 analysts observing the CME Group Inc. (CME) stock have set the 12-month price targets for the company’s shares at between $140.00 and $225.00. The consensus objective for the share price is $188.00, suggesting that the stock has a potential upside of 12.3% over the period. The median price target is 10.63% away from the current levels at $184.50.

FactSet Research has provided data showing that 21 brokerages have issued ratings for the stock. 3 analysts have rated it as a sell, while 1 advise that it is a overweight. 9 analysts have rated it as a buy and 8 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.

Raymond James upgraded the stock to “Outperform” from Mkt Perform on March 30, 2020 at a price target of $194. UBS upgraded its price target at $214-$233.

The current price level is -1.19%, -5.21%, and -13.46% away from its SMA20, SMA50, and SMA200 respectively, with the CME price moving above the 50-day SMA on July 28. CME Group Inc. (CME) stock is down -1.32% over the week and 2.19% over the past month. Its price is -17.30% year-to-date and -15.82% over the past year.

The stock last released its quarterly earnings report for quarter ended 3/30/2020, with the company’s earnings per share (EPS) of $2.33 above consensus estimates by $0.1. The company’s next earnings report is expected on 10/29/2020, with forecasts estimating quarterly EPS at $1.62 and $7.31 for whole year. CME’s earnings per share are forecast to grow by 7.50% this year and -0.30% over next year. Expected sales for next quarter are $1.22 billion, which analysts say will come at $5.17 billion for the current fiscal year and next year at $5.11 billion. In addition, estimates put the company’s current quarterly revenue at an average of $1.19 billion.

Its 12-month price target is $184.50. To reach the target analysts have set, the stock logically needs to grow 12.3 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $140.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $225.00.

Outstanding shares total 357.52M with insiders holding 1.56% of the shares and institutional holders owning 87.98% of the company’s common stock. The company has a return on investment of 6.70% and return on equity of 9.00%. The price to earnings ratio (P/E ratio) amounts to 24.93 while the forward price to earnings ratio is 22.73. The beta has a value of 0.30. Price to book ratio is 2.23 and price to sales ratio is 11.44.

According to a U.S. Securities and Exchange Commission filing, Washington Mutual Investors Fund has reduced its position in CME Group Inc. (CME) to 14,140,502 shares, mirroring a recent drop by 0.00%. Washington Mutual Investors Fund dumped 0.0 shares of CME Group Inc. common stock bringing its total worth to about $2.3 billion at the end of recent close, SEC documents show. Washington Mutual Investors Fund isn’t the only investment manager who changed stakes and is followed by Vanguard Total Stock Market Index, which sold off -0.12 million shares to end up with 10,221,092 shares worth $1.66 billion. American Funds Income Fund of Ame cut their holdings by 0.00% in the company over the course of the most recent quarter. It now holds a 2.72% position in CME Group Inc. thanks to 9.74 million shares amounting to $1.58 billion.

Related Posts:

  • No Related Posts

Factors To Monitor: CME Group Inc. (CME) and UnitedHealth Group Incorporated (UNH)

The stock of CME Group Inc. (CME) decreased by -0.67% to finish the standard trading session at $164.88. During that period, a total of 2170006 …

The stock of CME Group Inc. (CME) decreased by -0.67% to finish the standard trading session at $164.88. During that period, a total of 2170006 shares were traded, and this stock’s average trading volume is currently 1.94M shares per day. Important things to pay attention to when considering a stock’s current and future price are the 52-week high and low price points. Shares of CME Group Inc. (CME) are currently -26.84% below their 52-week high mark and 25.10% higher than the 52-week low mark.

Capital Research & Management Co…. opened a new position with shares of CME Group Inc. (CME) during the lastest quarter, according to the public company’s latest Form 13F filing with the US Securities and Exchange Commission (SEC). This particular institutional investor became the owner of 34,927,278 shares of the Financial Data & Stock Exchanges provider’s common stock, which is currently worth approximately $5.68 billion. According to the latest SEC filing from Capital Research & Management Co…., the firm held approximately 9.74% of CME Group Inc.. On a separate note, The Vanguard Group, Inc. entered a new position in CME Group Inc. stock during the lastest quarter, holdings valued at $4.49 billion. Institutional investors and hedge funds hold 88.50% of this public company’s common stock.

Turning now to this publicly-traded company’s past performance, we will explore different moving trends for CME. This stock lost -3.19% during the last week and rose 1.77% over the last one-month period. Shares of this organization’s stock fall -9.14% throughout the last quarter. Within the last six months, the stock has decreased -22.80%, with a full-year loss of -15.40%. At the time of writing, this stock’s year-to-date (YTD) price performance is now negative at -17.86%.

Out of a total of 21 brokerages that are currently covering CME Group Inc. (CME) stock, the average recommendation is “Overweight” according to WSJ. 1 equities research analyst has rated the stock with a “Overweight” recommendation, 9 analysts have given this stock a “Buy” recommendation, 8 analysts have recommended that investors “Hold” this stock, and 3 analysts have given this stock a “Sell” rating and 0 suggested “Underweight”. Analysts’ average 1-year price target, among all the brokerages, is $180.83.

Shares of UnitedHealth Group Incorporated (UNH) managed to reach a high of $309.75 and dropped down to a low of $300.00, before this stock settled at $306.68 at the end of the latest trading session. This organization’s stock has been displaying bullish momentum. Its Average True Range, or ATR, has fallen consistently after each of the most recent 14 trading sessions. Stock traders typically look at the ATR when they want to focus on technical analysis. At the time of writing, the 14-day ATR for UnitedHealth Group Incorporated (UNH) is sitting at 7.27. UnitedHealth Group Incorporated currently has a 52-week low of $187.72 with a 52-week high of $315.84. This organization has a debt-to-equity ratio of 0.91. This public company has a market cap of $292.96 billion, a beta of 0.72, a price-to-earnings-growth ratio of 1.36, and price-to-earnings ratio of 17.25.

BURKE RICHARD T, the Director of UnitedHealth Group Incorporated (UNH), sold 10,000 shares of UnitedHealth Group Incorporated stock in an exchange that took place on Jul 22. The shares were sold at an average price of $303.50 each, amounting to a total Sale worth $3,035,017. As of the close of the Sale, the Director now directly holds 1,376,500 shares of the organization’s stock, which is now worth about $422145020.0. The deal was disclosed in a Securities & Exchange Commission legal filing, which can be publicly viewed on the SEC website.

UnitedHealth Group Incorporated (UNH) most recently publicly disclosed its earnings results on July 15, 2020. The organization posted $7.12 earnings per share (EPS) during the three-month period, which was $1.84 higher than the consensus estimate of $5.28. The company experienced a positive return on equity of 24.90% and a positive net margin of 5.60%. UnitedHealth Group Incorporated reported revenue of $247.81B during the last year. During the year-ago, the company reported $17.78 EPS. Analysts forecast that UnitedHealth Group Incorporated will report EPS of $3.11 for the current fiscal year.

Stock traders are taking a renewed look at shares of UnitedHealth Group Incorporated. This stock’s current 14-day RSI is standing at 56.82%, with a 9-day RSI of 59.14%, and a 20-day RSI of 55.58%. The RSI, which stands for Relative Strength Index, is a widely-used oscillating indicator trusted by investors and traders alike. The RSI works within a range-bound space with values on a scale from 0 to 100. When the RSI line rises, the shares may be showing strength. The contrary is the case when the RSI line starts to fall. When using the RSI indicator, different time periods may be looked at. When using a shorter time frame, the RSI might be more volatile. A lot of traders keep their focus between the 30 and 70 marks on the RSI scale. A shift higher than 70 is widely-considered to demonstrate that the stock has entered overbought territory. Meanwhile, a drop below 30 indicates that it may be in oversold territory. Traders often use these levels to predict stock price reversals.

Related Posts:

  • No Related Posts

Alcoa Corporation (AA) drops -0.39%, marking lose by bears

The top two institutional holders are Vanguard Group, Inc. (The) with over 17.28 Million shares worth more than $106.43 Million. As of March 30, 2020, …

Alcoa Corporation (NYSE:AA) has a beta value of 2.3 and has seen 1,142,084 shares traded in the recent trading session. The company, currently valued at $2.4 Billion, closed the recent trade at $12.86 per share which meant it lost -$0.05 on the day or -0.39% during that session. The AA stock price is -82.5% off its 52-week high price of $23.47 and 59.88% above the 52-week low of $5.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.77 Million shares traded. The 3-month trading volume is 8.89 Million shares.

The consensus among analysts is that Alcoa Corporation (AA) is an Overweight stock at the moment, with a recommendation rating of 2.7. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 9 out of 13 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.65.

Despite being -0.39% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jul 27 when the AA stock price touched $13.31- or saw a rise of 2.83%. Year-to-date, Alcoa Corporation shares have moved -39.87%, while the 5-day performance has seen it change -1.04%. Over the past 30 days, the shares of Alcoa Corporation (NYSE:AA) have changed 17.69%. Short interest in the company has seen 14.79 Million shares shorted with days to cover at 1.66.

Wall Street analysts have a consensus price target for the stock at $13, which means that the shares’ value could jump 1.09% from current levels. The projected low price target is $11 while the price target rests at a high of $17. In that case, then, we find that the current price level is +32.19% off the targeted high while a plunge would see the stock lose -14.46% from current levels.

Alcoa Corporation (AA) estimates and forecasts

Figures show that Alcoa Corporation shares have outperformed across the wider relevant industry. The company’s shares have lost -12.24% over the past 6 months, with this year growth rate of 40.4%, compared to -29.7% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -47.7% and 19.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be -10.3%.

6 analysts offering their estimates for the company have set an average revenue estimate of $2.15 Billion for the current quarter. 5 have an estimated revenue figure of $2.22 Billion for the next quarter concluding in December 01, 2020. Year-ago sales stood $2.57 Billion and $2.44 Billion respectively for this quarter and the next, and analysts expect sales will grow by -16.3% for the current quarter and -8.9% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -34.1% over the past 5 years. Earnings growth for 2020 is a modest -559.7%.

Alcoa Corporation (NYSE:AA)’s Major holders

Insiders own 0.38% of the company shares, while shares held by institutions stand at 77.21% with a share float percentage of 77.5%. Investors are also buoyed by the number of investors in a company, with Alcoa Corporation having a total of 450 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 17.28 Million shares worth more than $106.43 Million. As of March 30, 2020, Vanguard Group, Inc. (The) held 9.29% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 10.48 Million shares as of March 30, 2020. The firm’s total holdings are worth over $64.53 Million and represent 5.63% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Growth Fund Of America Inc. As of March 30, 2020, the former fund manager holds about 2.94% shares in the company for having 5468156 shares of worth $33.68 Million while later fund manager owns 5.35 Million shares of worth $32.98 Million as of March 30, 2020, which makes it owner of about 2.88% of company’s outstanding stock.

Related Posts:

  • No Related Posts

Shares in Eventbrite, Inc. (EB) -59.05 % down, YTD

The top two institutional holders are Vanguard Group, Inc. (The) with over 4.97 Million shares worth more than $36.27 Million. As of March 30, 2020, …

Eventbrite, Inc. (NYSE:EB) has a beta value of 0 and has seen 1,128,258 shares traded in the last trading session. The company, currently valued at $749.2 Million, closed the last trade at $8.26 per share which meant it lost -$0.42 on the day or -4.84% during that session. The EB stock price is -177.24% off its 52-week high price of $22.9 and 30.87% above the 52-week low of $5.71. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.3 Million shares traded. The 3-month trading volume is 2.11 Million shares.

The consensus among analysts is that Eventbrite, Inc. (EB) is an Overweight stock at the moment, with a recommendation rating of 2.5. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 4 out of 6 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.5.

Despite being -4.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jul 28 when the EB stock price touched $8.80-6 or saw a rise of 6.14%. Year-to-date, Eventbrite, Inc. shares have moved -59.05%, while the 5-day performance has seen it change -3.62%. Over the past 30 days, the shares of Eventbrite, Inc. (NYSE:EB) have changed 3.25%. Short interest in the company has seen 8.39 Million shares shorted with days to cover at 3.98.

Wall Street analysts have a consensus price target for the stock at $10.6, which means that the shares’ value could jump 28.33% from current levels. The projected low price target is $10 while the price target rests at a high of $12. In that case, then, we find that the current price level is +45.28% off the targeted high while a plunge would see the stock lose 21.07% from current levels.

Eventbrite, Inc. (EB) estimates and forecasts

Figures show that Eventbrite, Inc. shares have outperformed across the wider relevant industry. The company’s shares have lost -63.04% over the past 6 months, with this year growth rate of 214.29%, compared to -1.1% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -177.8% and 2.8% for the next quarter. Revenue growth from the last financial year stood is estimated to be -55.2%.

6 analysts offering their estimates for the company have set an average revenue estimate of $13.46 Million for the current quarter. 6 have an estimated revenue figure of $29.13 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $80.76 Million and $82.05 Million respectively for this quarter and the next, and analysts expect sales will grow by -83.3% for the current quarter and -64.5% for the next.

Earnings growth for 2020 is a modest +50.9% while over the next 5 years, the company’s earnings are expected to increase by 46.4%.

Eventbrite, Inc. (NYSE:EB)’s Major holders

Insiders own 0.19% of the company shares, while shares held by institutions stand at 78.61% with a share float percentage of 78.76%. Investors are also buoyed by the number of investors in a company, with Eventbrite, Inc. having a total of 200 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 4.97 Million shares worth more than $36.27 Million. As of March 30, 2020, Vanguard Group, Inc. (The) held 7.4% of shares outstanding.

The other major institutional holder is Foxhaven Asset Management, LP, with the holding of over 4.23 Million shares as of March 30, 2020. The firm’s total holdings are worth over $30.89 Million and represent 6.3% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. As of March 30, 2020, the former fund manager holds about 2.49% shares in the company for having 1674676 shares of worth $12.23 Million while later fund manager owns 1.47 Million shares of worth $10.76 Million as of March 30, 2020, which makes it owner of about 2.2% of company’s outstanding stock.

Related Posts:

  • No Related Posts

Canopy Growth Corporation (NYSE:CGC) 14.86% gain reignites investor interest in company’s stock

Canopy Growth Corporation (NYSE:CGC) traded at $19.48 at last check on Tuesday, Jul 28, making an upward move of 14.86% on its previous day’s …

Canopy Growth Corporation (NYSE:CGC) traded at $19.48 at last check on Tuesday, Jul 28, making an upward move of 14.86% on its previous day’s price.

Looking at the stock we see that its previous close was $16.96 and the beta (5Y monthly) reads 2.42 with the day’s price range being $17.13 – 19.59. In terms of its 52-week price range, CGC has a high of $34.34 and a low of $9. The company’s stock has gained about 22.13% over that past 30 days.

There have been no upward or downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the CGC stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Buy.

Based on estimates by 21 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 13 have rated the Canopy Growth Corporation (CGC) stock as a Hold, while 4 rate it as a Buy. 1 analysts rate it as outperform while none of them rated it as underperform, whereas 3 suggests the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.

Looking further, we note that the PEG ratio for the CGC stock currently stands at 0, and the current price level is 14.49% off its SMA20 and 13.09% from its 50-day simple moving average. The RSI (14) is pointing at 65.86 while the volatility over the past week is 5.53% and drops to 4.94% over the past one month. The beta value is 0, while the average true range (ATR) is currently pointing at 0.89. The average price target for the stock over the next 12 months is $17.32, with the estimates having a low of $11.67 and a high of $23. These price ends are -40.09% and +18.07% off the current price level respectively, although investors could be excited at the prospect of a -11.86% if the CGC share price touches on the median price of $17.17.

Coming back to Canopy Growth Corporation (NYSE:CGC), we note that the average 3-month trading volume was 6.1 Million, while that of the preceding 10-day period stands at 2.56 Million. Current shares outstanding are 368.99 Million.

According to data from Thomson Reuters, insiders hold 41.62% of the company’s shares while institutions hold 13.35%. The data shows that short shares as of July 14, 2020, stood at 41.75 Million at a short ratio of 10.72. This represents a 11.29% Short interest in Shares outstanding on July 14, 2020. Shares short dropped in July from the previous month at 46.77 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -7.63% down in year-to-date price movement.

Related Posts:

  • No Related Posts